Trading / Browse Companies / Orca Bio stock

Orca Bio Stock

orcabio.comBioTechFounded: 2016Funding to Date: $291.19MM

Orca Bio is the developer of high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Buy or sell Orca Bio stock
OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Orca Bio, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Orca Bio investors also invested in these private companies

Lightspeed Venture Partners
DCVC
8VC

Team

Management Team

Ivan Dimov Ph.D
Co-Founder & Chief Executive Officer
Jeroen Bekaert
Chief Operating Officer
Nathaniel Fernhoff Ph.D
Co-Founder & Chief Science Officer
Dan Kirby
Chief Commercial Officer

Board Members

Alex Kolicich
8VC
Jonathan MacQuitty Ph.D
Lightspeed Venture Partners

Other companies like Orca Bio in the BioTech sector

Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Ginkgo Bioworks
Sector
BioTech
Last Round Est. Valuation
$4.89B
PROCEPT BioRobotics
Sector
BioTech
Last Round Est. Valuation
$872.62MM
Synthego
Sector
BioTech
Last Round Est. Valuation
$486.63MM
eFFECTOR Therapeutics
Sector
BioTech
Last Round Est. Valuation
$186.12MM
Human Longevity
Sector
BioTech
Last Round Est. Valuation
$50.4MM
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Arsenal Biosciences
Sector
BioTech
Last Round Est. Valuation
$185MM
Caris Life Sciences
Sector
BioTech
 
 

Trending Companies

Frequently Asked Questions